Qube Research & Technologies LTD Assertio Holdings, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 132,756 shares of ASRT stock, worth $179,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
132,756Holding current value
$179,220% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding ASRT
# of Institutions
114Shares Held
37.2MCall Options Held
755KPut Options Held
39.5K-
Nantahala Capital Management, LLC New Canaan, CT9.27MShares$12.5 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$6.03 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.38MShares$3.21 Million0.01% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.31MShares$3.12 Million0.0% of portfolio
-
Russell Investments Group, Ltd.2.2MShares$2.96 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $65M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...